AMO Pharma recently presented data from its trial investigating a drug called tideglusib.
An international study has found an association between exercise and symptom onset in people with dysferlinopathies (limb girdle muscular dystrophy type 2B and Miyoshi myopathy).
Poor bone health is common in individuals with Duchenne muscular dystrophy.
This study will test whether a type of B vitamin is beneficial for individuals with the condition.
We would like to invite you to take part in a study about anxiety in Duchenne muscular dystrophy.
A recent preclinical study has identified a potential therapeutic target for Charcot Marie Tooth disease (CMT).
Dr Linda Popplewell and Professor George Dickson from Royal Holloway University took to Facebook last week to answer your questions on gene therapy.
The Human Fertilisation and Embryology Authority (HFEA) has given permission to doctors at the Newcastle Fertility Centre to perform the mitochondrial donation IVF technique
Acceleron Pharmaceuticals has announced preliminary results from its phase 2 trial testing ACE-083 in adults with facioscapulohumeral muscular dystrophy (FSHD).
Disappointing news for people with Duchenne as Raxone gets negative opinion.